- Home
- PBYI vs CHN Comparison
PBYI vs CHN Comparison
Compare PBYI & CHN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- CHN
- Stock Information
- Founded
- PBYI 2010
- CHN 1992
- Country
- PBYI United States
- CHN United States
- Employees
- PBYI N/A
- CHN N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- CHN Investment Managers
- Sector
- PBYI Health Care
- CHN Finance
- Exchange
- PBYI Nasdaq
- CHN Nasdaq
- Market Cap
- PBYI 138.4M
- CHN 128.4M
- IPO Year
- PBYI N/A
- CHN N/A
- Fundamental
- Price
- PBYI $2.91
- CHN $12.26
- Analyst Decision
- PBYI Strong Buy
- CHN
- Analyst Count
- PBYI 1
- CHN 0
- Target Price
- PBYI $7.00
- CHN N/A
- AVG Volume (30 Days)
- PBYI 280.0K
- CHN 31.8K
- Earning Date
- PBYI 05-08-2025
- CHN 01-01-0001
- Dividend Yield
- PBYI N/A
- CHN 0.19%
- EPS Growth
- PBYI 143.51
- CHN N/A
- EPS
- PBYI 0.77
- CHN N/A
- Revenue
- PBYI $232,668,000.00
- CHN N/A
- Revenue This Year
- PBYI N/A
- CHN N/A
- Revenue Next Year
- PBYI N/A
- CHN N/A
- P/E Ratio
- PBYI $3.78
- CHN N/A
- Revenue Growth
- PBYI 2.67
- CHN N/A
- 52 Week Low
- PBYI $2.23
- CHN $9.00
- 52 Week High
- PBYI $5.20
- CHN $12.98
- Technical
- Relative Strength Index (RSI)
- PBYI 44.50
- CHN 52.61
- Support Level
- PBYI $2.88
- CHN $12.00
- Resistance Level
- PBYI $3.14
- CHN $12.51
- Average True Range (ATR)
- PBYI 0.16
- CHN 0.33
- MACD
- PBYI 0.00
- CHN 0.07
- Stochastic Oscillator
- PBYI 11.36
- CHN 59.03
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About CHN China Fund Inc. (The)
CHINA FUND INC is a non-diversified, closed-end management investment company. Its investment objective is a long-term capital appreciation which it seeks to achieve by investing in equity securities with trading in China and outside China. It invests in various industries such as Insurance, Entertainment, Machinery, Electrical Equipment, Beverages, Hotels, Restaurants, and Leisure among others.